F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 33.9 SEK -0.44% Market Closed
Market Cap: 461.7m SEK
Have any thoughts about
Fluoguide AS?
Write Note

EV/OCF
Enterprise Value to OCF

-7.2
Current
-15.1
Median
6
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-7.2
=
Enterprise Value
375.7m SEK
/
Operating Cash Flow
-33.5m DKK
All Countries
Close
Market Cap EV/OCF
DK
Fluoguide AS
STO:FLUO
420.7m SEK -7.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 051.4
US
Abbvie Inc
NYSE:ABBV
301B USD 21.3
US
Amgen Inc
NASDAQ:AMGN
162B USD 28.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD -128.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 11
US
Epizyme Inc
F:EPE
94.1B EUR -477
AU
CSL Ltd
ASX:CSL
138B AUD 35.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 19.2
US
Seagen Inc
F:SGT
39.3B EUR -74.6
NL
argenx SE
XBRU:ARGX
34.1B EUR -126.8
 
DK
F
Fluoguide AS
STO:FLUO
Average EV/OCF: 23.3
Negative Multiple: -7.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 051.4
US
Abbvie Inc
NYSE:ABBV
21.3
US
Amgen Inc
NASDAQ:AMGN
28.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -128.2
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477
AU
CSL Ltd
ASX:CSL
35.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.8

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More